Tilak Mandadi is EVP, Chief DDAT Officer of CVS HEALTH Corp. Currently has a direct ownership of 99,747 shares of CVS, which is worth approximately $5.25 Million. The most recent transaction as insider was on Nov 30, 2024, when has been sold 50,125 shares (Common Stock (RSU)) at a price of $59.85 per share, resulting in proceeds of $2,999,981. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 99.7K
146.81% 3M change
393.09% 12M change
Total Value Held $5.25 Million

Tilak Mandadi Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 30 2024
BUY
Grant, award, or other acquisition
$2,999,981 $59.85 p/Share
50,125 Added 33.45%
99,747 Common Stock (RSU)
Aug 31 2024
SELL
Payment of exercise price or tax liability
$749,672 $57.24 p/Share
13,097 Reduced 24.48%
40,414 Common Stock
Apr 01 2024
BUY
Grant, award, or other acquisition
-
16,339 Added 16.46%
82,904 Common Stock (RSU)
Aug 31 2023
SELL
Payment of exercise price or tax liability
$850,664 $65.17 p/Share
13,053 Reduced 39.22%
20,229 Common Stock
Aug 31 2022
BUY
Grant, award, or other acquisition
-
99,847 Added 50.0%
99,847 Common Stock (RSU)

Also insider at

MGM
MGM Resorts International Consumer Cyclical
TM

Tilak Mandadi

EVP, Chief DDAT Officer
Las Vegas, NV

Track Institutional and Insider Activities on CVS

Follow CVS HEALTH Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CVS shares.

Notify only if

Insider Trading

Get notified when an Cvs Health Corp insider buys or sells CVS shares.

Notify only if

News

Receive news related to CVS HEALTH Corp

Track Activities on CVS